Cyxone Future Growth
Future criteria checks 0/6
Cyxone's revenue and earnings are forecast to decline at 122.2% and 20.2% per annum respectively while EPS is expected to decline by 6.9% per annum.
Key information
-20.2%
Earnings growth rate
-6.9%
EPS growth rate
Biotechs earnings growth | 45.3% |
Revenue growth rate | -122.2% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 27 Feb 2024 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | N/A | -39 | -37 | -37 | 1 |
12/31/2025 | N/A | -38 | -35 | -35 | 1 |
12/31/2024 | N/A | -28 | -26 | -26 | 1 |
3/31/2024 | 5 | -22 | -25 | -18 | N/A |
12/31/2023 | 5 | -23 | -26 | -19 | N/A |
9/30/2023 | 6 | -17 | -32 | -18 | N/A |
6/30/2023 | 6 | -23 | -33 | -21 | N/A |
3/31/2023 | 8 | -31 | -46 | -36 | N/A |
12/31/2022 | 6 | -42 | -49 | -41 | N/A |
9/30/2022 | N/A | -54 | -51 | -50 | N/A |
6/30/2022 | N/A | -54 | -55 | -54 | N/A |
3/31/2022 | N/A | -53 | -45 | -44 | N/A |
12/31/2021 | N/A | -45 | -44 | -43 | N/A |
9/30/2021 | N/A | -43 | -43 | -43 | N/A |
6/30/2021 | N/A | -45 | -39 | -44 | N/A |
3/31/2021 | N/A | -47 | -45 | -45 | N/A |
12/31/2020 | N/A | -49 | -45 | -45 | N/A |
9/30/2020 | N/A | -46 | -43 | -43 | N/A |
6/30/2020 | N/A | -46 | -46 | -41 | N/A |
3/31/2020 | N/A | -39 | -36 | -36 | N/A |
12/31/2019 | N/A | -35 | -35 | -35 | N/A |
9/30/2019 | N/A | -47 | -57 | -43 | N/A |
6/30/2019 | N/A | -39 | -49 | -36 | N/A |
3/31/2019 | N/A | -36 | -49 | -35 | N/A |
12/31/2018 | N/A | -32 | -43 | -30 | N/A |
9/30/2018 | N/A | -14 | -19 | -13 | N/A |
6/30/2018 | N/A | -11 | -16 | -10 | N/A |
3/31/2018 | N/A | -10 | -13 | -7 | N/A |
12/31/2017 | N/A | -9 | N/A | -5 | N/A |
9/30/2017 | 0 | -7 | N/A | -6 | N/A |
6/30/2017 | N/A | -7 | N/A | -8 | N/A |
3/31/2017 | N/A | -5 | N/A | -5 | N/A |
12/31/2016 | N/A | -4 | N/A | -4 | N/A |
12/31/2015 | 0 | 0 | N/A | 0 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: CYXO BTA is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: CYXO BTA is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: CYXO BTA is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: CYXO BTA is forecast to have no revenue next year.
High Growth Revenue: CYXO BTA is forecast to have no revenue next year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if CYXO BTA's Return on Equity is forecast to be high in 3 years time